general topic


PUBLISHED: 23-03-2020

AJOPS logo

An update on the management of nerve gaps

William Alexander MBBS FRACS (Plast),1 Christopher Coombs MBBS FRACS (Plast)1,2


Royal Children’s Hospital
Parkville, Victoria


Section Editor
Australasian Journal of Plastic Surgery
St Leonards, New South Wales

Name: William Alexander
Address:Royal Children’s Hospital
50 Flemington Road
Parkville, Victoria, 3052
Email: [email protected]
Phone: +61 (0)417 125 434
Citation: Alexander W, Coombs C. An update on the management of nerve gaps. Australas J Plast Surg. 2020; 3(1):3–7.
This feature was invited by the editors-in-chief and was not subject to external double-blind peer review.
Copyright © 2020. Authors retain their copyright in the article. This is an open access article distributed under the Creative Commons Attribution Licence which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Section: General
Keywords: autografts, allografts, nerve tissue, reconstructive surgical procedures


The reconstructive options for nerve gaps are now broader than ever before but outcomes can be disappointing. Nerves repaired under tension do not function well1 with autologous nerve grafts being favoured in this setting. 2 Autografts—as opposed to allografts and alloplasts—are still considered the gold standard against which other options are measured. Mixed and motor nerve autograft reconstruction, in particular, is superior to allografts3 but the functional outcomes are still not consistently successful. 4


With respect to nerve autografts, typically a donor sensory nerve is harvested and reversed. However, there is no strong evidence of improved functional outcomes with reversal of the graft; 5 despite the intuitive theory of distal axonal loss via branching. Furthermore, the architecture of motor and sensory nerve autografts are different6,7 and animal model motor nerve autografts produce better results in motor and mixed nerve gaps. 8

Despite modern microsurgical nerve autografting techniques, approximately 50–75 per cent of patients have modest functional outcomes. 9 For this reason, innovative adjunctive techniques have been recently investigated. Brief, low frequency electrical stimulation, 10 end-to-side sensory nerve input into nerve grafts11 and nerve bridges are in their infancy in clinical use. 12 Fat grafting around nerve grafts have shown promising results, particularly in animal studies in the setting of direct nerve repair, but there is not enough evidence yet to recommend routine clinical use. 13-20

Schwann cell senescence is the proposed theory explaining the poor results of long nerve grafts. Cells in longer (~3cm) autografts and allografts, in a rat model, express higher numbers of senescence markers (senescence associated β-galactosidase, p16(INK4A) and IL6) than those in grafts <3 cm. This is related to the transient expression of growth-associated genes at time of injury, leading to a reduced regenerative capacity. 21–23 This finding is more marked in acellular nerve allografts (ANAs) than autografts, at all lengths examined. 21 Gordon argues that this senescence can be partially ameliorated with electrical stimulation but also with nerve stump ‘protection’—inserting autografts between distal donor nerves and a distal denervated stump, via perineural windows. 22 This is a similar theory to that of the ‘baby-sitter’ concept introduced by Terzis and colleagues24 but with a focus on senescence prevention rather than motor end-plate support. It also raises the question of end-to-side (ETS) neurorrhaphy, which, despite being described as early as 187325 and 1903,26 fell out of favour until it was re-examined further by Viterbo27–29 who showed histological evidence of axonal growth in the distal recipient. It has been considered a controversial technique, as the initially strong animal results have not been supported in subsequent human trials. 30 More recently, Reece et al published ETS nerve grafting use for the treatment of erectile dysfunction post radical prostatectomy with encouraging results. 31

The mechanism by which ETS neurorrhaphy is believed to work is axonal sprouting (both terminal and collateral) and while some authors argue that the donor nerve does not need an injury/opening to be made in the epi- or perineurium, others argue this is vital, particularly in the case of motor nerves. 27,29

Catapano et al elegantly combined the techniques of ‘pathway protection’ and ETS neurorrhaphy by coapting the end of a cross-facial nerve graft to a contralateral infraorbital nerve branch, to improve axonal growth and thus muscle excursion in a facial nerve palsy cohort of patients. 11 While no human trial results are available at this stage, a variation of this technique has been adopted at the authors’ institution.

Nerve conduits and acellular nerve allografts

Nerve conduits and ANAs have been developed because autografts are in limited supply and incur a donor deficit. Conduits have undergone multiple iterations over time—as early as 1880 Gluck used bone graft, 32 and then in 1891 Von Bunger trailed a brachial artery conduit for the sciatic nerve in a dog. 33 More recently, alloplasts such as silicone, then biocompatible (collagen, polyglycolic acid) materials were used. Even more recently these have been improved by incorporating structural elements that allow the delivery of molecular or cellular based therapies: for example, seeded with Schwann cells or neurotrophic factors. 18 Nerves with diameters of 3–7 mm can reliably reconstructed with nerve conduits over short distances (maximum 3 cm), 9,34 with better results in sensory-only nerves. 35 Other novel autograft substitutes include muscle grafts, 36 vein graft (with or without Schwann cells within the lumen), 37–39 and spider silk in a pig model. 40 Acellular nerve allografts provide an architectural scaffold to support axonal growth and Schwann cells but without the immunogenicity. Similar to conduits, these have proven results over short sensory gaps (<25 mm) 18 but are consistently inferior to autografts at all compared lengths. 21,41 Results have been enhanced in animal models by surrounding the ANA suture lines with controlled release glial cell line derived neurotrophic factors, essentially trying to create a regenerative environment similar to an autograft. 42

Nerve transfer

An alternative technique for nerve gap reconstruction is nerve transfer. Indeed, some experienced surgeons would argue that we are moving into the ‘post-grafting era of nerve surgery’. 43 The benefits of nerve transfer are well known, but include a single neurorrhaphy, operating outside the zone of injury and bringing the donor nerve closer to the target. The donor deficit can be negligible, less even than that of a nerve graft. 44 A large number of nerve transfers have been described for various indications and, in the situations where grafts and transfers can be directly compared, the outcomes for transfers are potentially better than autologous nerve grafting. 43,45


In summary, nerve autografts and transfers are the current gold standard of management in nerve gap reconstruction. The presence of Schwann cells, basal lamina endoneurial tubes, neurotrophic factors and adhesion molecules help to guide the regrowth of axons. Substitutes such as off-the-shelf or biologic conduits and ANAs are useful only in short gaps with currently available technology; with end-to-side neurorrhaphy potentially evolving as a stand-alone reconstruction in particular clinical situations. The experimental field in nerve surgery is tremendously exciting, in particular the recent results of optogenetics (genetically modifying neural cells to express light-sensitive channels, thus enabling precise control of neural activation without directly contacting the nerve) which have shown positive results in directly repaired sciatic nerves in animals18,46 and could well be the next big step towards reliable outcomes in human nerve surgery.


The authors have no financial or commercial conflicts of interest to disclose.


  1. Highet WB, Sanders FK. The effects of stretching nerves after suture. BJS. 1943;30(120):355–369.

  2. liKalomiri DE, Soucacos PN, Beris AE. Nerve grafting in peripheral nerve microsurgery of the upper extremity. Microsurg. 1994;15(7):506–11. PMid:7968483

  3. Moore AM, Wagner IJ, Fox IK. Principles of nerve repair in complex wounds of the upper extremity. Semin Plast Surg. 2015;29(1):40–47. PMid:25685102 PMCid:PMC4317271

  4. Seidel JA, Koenig R, Antoniadis G, Richter HP, Kretschmer T. Surgical treatment of traumatic peroneal nerve lesions. Neurosurg. 2008;62(3):664–673; discussion 664-673. PMid:18425013

  5. Roberts SE, Thibaudeau S, Burrell JC, Zager EL, Cullen DK, Levin LS. To reverse or not to reverse? A systematic review of autograft polarity on functional outcomes following peripheral nerve repair surgery. Microsurg. 2017;37(2):169–174. PMid:27935644

  6. Brushart TM. Motor axons preferentially reinnervate motor pathways. J Neurosci. 1993;13(6):2730–2738. PMid:8501535 PMCid:PMC6576505

  7. Brushart TM, Gerber J, Kessens P, Chen YG, Royall RM. Contributions of pathway and neuron to preferential motor reinnervation. J Neurosci. 1998;18(21):8674–8681. PMid:9786974 PMCid:PMC6793544

  8. Moradzadeh A, Borschel GH, Luciano JP, Whitlock EL, Hayashi A, Hunter DA, Mackinnon SE. The impact of motor and sensory nerve architecture on nerve regeneration. Exp Neurol. 2008;212(2):370–376. PMid:18550053 PMCid:PMC2761727

  9. Bassilios Habre S, Bond G, Jing XL, Kostopoulos E, Wallace RD, Konofaos P. The surgical management of nerve gaps: present and future. Ann Plast Surg. 2018;80(3):252–261. PMid:29166306

  10. Willand MP, Nguyen MA, Borschel GH, Gordon T. Electrical stimulation to promote peripheral nerve regeneration. Neurorehabil Neural Repair. 2016;30(5):490–496. PMid:26359343

  11. Catapano J, Demsey DR, Ho ES, Zuker RM, Borschel GH. Cross-face nerve grafting with infraorbital nerve pathway protection: anatomic and histomorphometric feasibility study. Plast Reconstr Surg Glob Open. 2016;4(9):e1037. PMid:27757349 PMCid:PMC5055015

  12. Gordon T, Eva P, Borschel GH. Delayed peripheral nerve repair: methods, including surgical 'cross-bridging' to promote nerve regeneration. Neural Reg Res. 2015;10(10):1540–1544. PMid:26692833 PMCid:PMC4660729

  13. Al-Majed AA, Brushart TM, Gordon T. Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur J Neurosci. 2000;12(12):4381–4390. PMid:11122348

  14. Al-Majed AA, Neumann CM, Brushart TM, Gordon T. Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci. 2000;20(7):2602–2608. PMid:10729340 PMCid:PMC6772244

  15. Al-Majed AA, Tam SL, Gordon T. Electrical stimulation accelerates and enhances expression of regeneration-associated genes in regenerating rat femoral motoneurons. Cell Mol Neurobiol. 2004;24(3):379–402. PMid:15206821

  16. Geremia NM, Gordon T, Brushart TM, Al-Majed AA, Verge VM. Electrical stimulation promotes sensory neuron regeneration and growth-associated gene expression. Exp Neurol. 2007;205(2):347–359. PMid:17428474

  17. Gordon T, Amirjani N, Edwards DC, Chan KM. Brief post-surgical electrical stimulation accelerates axon regeneration and muscle reinnervation without affecting the functional measures in carpal tunnel syndrome patients. Exp Neurol. 2010;223(1):192–202. PMid:19800329

  18. Kubiak CA, Kung TA, Brown DL, Cederna PS, Kemp SWP. State-of-the-art techniques in treating peripheral nerve injury. Plast Reconstr Surg. 2018;141(3):702–710. PMid:29140901

  19. Pockett S, Gavin RM. Acceleration of peripheral nerve regeneration after crush injury in rat. Neurosci Lett. 1985;59(2):221–224.

  20. Tuncel U, Kostakoglu N, Turan A, Cevik B, Cayli S, Demir O, Elmas C. The effect of autologous fat graft with different surgical repair methods on nerve regeneration in a rat sciatic nerve defect model. Plast Reconstr Surg. 2015;136(6):1181–1191. PMid:26273733

  21. Saheb-Al-Zamani M, Yan Y, Farber SJ, Hunter DA, Newton P, Wood MD, Stewart SA, Johnson PJ, Mackinnon SE. Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Expl Neurol. 2013;247:165–177. PMid:23644284 PMCid:PMC3863361

  22. Gordon T. Electrical stimulation to enhance axon regeneration after peripheral nerve injuries in animal models and humans. Neurotherapeutics. 2016;13(2):295–310. PMid:26754579 PMCid:PMC4824030

  23. Poppler LH, Ee X, Schellhardt L, Hoben GM, Pan D, Hunter DA, Yan Y, Moore AM, Snyder-Warwick AK, Stewart SA, Mackinnon SE, Wood MD. Axonal growth arrests after an increased accumulation of schwann cells expressing senescence markers and stromal cells in acellular nerve allografts. Tissue Engineering. Part A. 2016;22(13-14):949–961. PMid:27297909 PMCid:PMC4948214

  24. Kalantarian B, Rice DC, Tiangco DA, Terzis JK. Gains and losses of the XII-VII component of the ‘baby-sitter’ procedure: a morphometric analysis. J Reconstr Microsurg. 1998;14(7):459–471. PMid:9819092

  25. Letievant E. Traite des sections nerveuses. Paris, France: JB Bailliere et Fils, 1873.

  26. Ballance CA, Ballance HA, Stewart P. Remarks on the operative treatment of chronic facial palsy of peripheral origin. BMJ. 1903;1(2209):1009–1013. PMid:20760866 PMCid:PMC2514031

  27. Pannucci C, Myckatyn TM, Mackinnon SE, Hayashi A. End-to-side nerve repair: review of the literature. Restor Neurol Neuros. 2007;25(1):45–63.

  28. Viterbo F, Amr AH, Stipp EJ, Reis FJ. End-to-side neurorrhaphy: past, present, and future. Plast Reconstr Surg. 2009;124(6 Suppl):e351–358. PMid:19952703

  29. Konofaos P, Bassilios Habre S, Wallace RD. End-to-side nerve repair: current concepts and future perspectives. Ann Plast Surg. 2018;81(6):736–740. PMid:30362965

  30. Myckatyn TM, Mackinnon SE. A review of research endeavors to optimize peripheral nerve reconstruction. Neurol Res. 2004;26(2):124–138. PMid:15072631

  31. Reece JC, Dangerfield DC, Coombs CJ. End-to-side somatic-to-autonomic nerve grafting to restore erectile function and improve quality of life after radical prostatectomy. Eur Urol. 2019;76(2):189–196. PMid:30955973

  32. Gluck T. Ueber neuroplastik auf dem wege der transplantation. Arch Klin Chir. 1880;25:606-616.

  33. Bunger O. Degenerations und regenerations vorgange am nerven nach verletzungen. Beitr Pathol Anat Al. 1989;10:312–393.

  34. Kostopoulos E, Konofaos P, Frazer M, Terzis JK. Tubulization techniques in brachial plexus surgery in an animal model for long-nerve defects (40 mm): a pilot study. Ann Plast Surg. 2010;64(5):614–621. PMid:20395801

  35. Mackinnon SE, Dellon AL. A study of nerve regeneration across synthetic (Maxon) and biologic (collagen) nerve conduits for nerve gaps up to 5 cm in the primate. J Reconstr Microsurg. 1990;6(2):117–121. PMid:2352218

  36. Mligiliche N, Kitada M, Ide C. Grafting of detergent-denatured skeletal muscles provides effective conduits for extension of regenerating axons in the rat sciatic nerve. Arch Hist Cytol. 2001;64(1):29–36. PMid:11310502

  37. Chiu DT, Strauch B. A prospective clinical evaluation of autogenous vein grafts used as a nerve conduit for distal sensory nerve defects of 3 cm or less. Plast Reconstr Surg. 1990;86(5):928–934. PMid:2236318

  38. Strauch B, Ferder M, Lovelle-Allen S, Moore K, Kim DJ, Llena J. Determining the maximal length of a vein conduit used as an interposition graft for nerve regeneration. J Reconstr Microsurg. 1996;12(8):521–527. PMid:8951120

  39. Strauch B, Rodriguez DM, Diaz J, Yu HL, Kaplan G, Weinstein DE. Autologous schwann cells drive regeneration through a 6-cm autogenous venous nerve conduit. J Reconstr Microsurg. 2001;17(8):589–595; discussion 596-587. PMid:11740653

  40. Radtke C, Allmeling C, Waldmann KH, Reimers K, Thies K, Schenk HC, Hilmer A, Guggenheim M, Brandes G, Vogt PM. Spider silk constructs enhance axonal regeneration and remyelination in long nerve defects in sheep. Plos One. 2011;6(2):e16990. PMid:21364921 PMCid:PMC3045382

  41. Yan Y, Wood MD, Hunter DA, Ee X, Mackinnon SE, Moore AM. The effect of short nerve grafts in series on axonal regeneration across isografts or acellular nerve allografts. J Hand Surg Am. 2016;41(6):e113–121. PMid:26880495

  42. Tajdaran K, Gordon T, Wood MD, Shoichet MS, Borschel GH. A glial cell line-derived neurotrophic factor delivery system enhances nerve regeneration across acellular nerve allografts. Acta Biomater. 2016;29:62–70. PMid:26441127

  43. Domeshek LF, Novak CB, Patterson MM, Hasak JM, Yee A, Kahn LC, Mackinnon SE. Nerve transfers—a paradigm shift in the reconstructive ladder. Plast Reconstr Surg Glob Open. 2019:1. PMid:31624686 PMCid:PMC6635215

  44. Meek MF, Coert JH, Robinson PH. Poor results after nerve grafting in the upper extremity: Quo vadis? Microsurg. 2005;25(5):396–402. PMid:16032723

  45. Seruya M, Shen SH, Fuzzard S, Coombs CJ, McCombe DB, Johnstone BR. Spinal accessory nerve transfer outperforms cervical root grafting for suprascapular nerve reconstruction in neonatal brachial plexus palsy. Plast Reconstr Surg. 2015;135(5):1431–1438. PMid:25835244

  46. Ward PJ, Jones LN, Mulligan A, Goolsby W, Wilhelm JC, English AW. Optically-induced neuronal activity is sufficient to promote functional motor axon regeneration in vivo. Plos One. 2016;11(5):e0154243. PMid:27152611 PMCid:PMC4859548